Camson Biotechnologies has reported a 52 per cent increase in net profit at Rs 7.30 crore in the third quarter of this fiscal against Rs 4.81 crore registered in the same period last year. Income rose 49 per cent to Rs 32.33 crore in the third quarter. Mr Dhirendra Kumar, Managing Director, Camson Biotech, said, “we expect the growing awareness among farmers on our zero residue biocides and unique hybrid seeds will continue to drive demand for Camson Biotechnologies' products.”
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.